Informations générales (source: ClinicalTrials.gov)
Controlled, Multicenter Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
Interventional
N/A
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
mars 2025
avril 2028
13 août 2025
Multicenter controlled study of sleep disorders in isolated REM Behavior Disorder and
Parkinson's disease (SOMPARK)
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP Assistance publique - Hôpitaux de Paris | 13/12/2025 07:38:57 | Contacter | |||
| AP-HP - Hôpital La Pitié-Salpêtrière | |||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHU de Clermont-Ferrand - 63000 - Clermont-Ferrand - France | Maria-Livia FANTINI, MD | Contact (sur clinicalTrials) | |||
| CHU de Lille - 59037 - Lille - France | Lise LANVIN, MD | Contact (sur clinicalTrials) | |||
| CHU de Lyon - 69004 - Lyon - France | Laure PETER-DEREX, MD | Contact (sur clinicalTrials) | |||
| CHU de Nantes - 44093 - Nantes - France | Laurène LECLAIR-VISONNEAU, MD | Contact (sur clinicalTrials) | |||
| CHU de Nîmes - 30000 - Nîmes - France | Beatriz ABRIL, MD | Contact (sur clinicalTrials) | |||
| CHU Pitié Salpêtrière - 75013 - Paris - France | Pauline DODET, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
Common to all groups:
- Age superior 18 years
- Patients who have received complete information about the study from an investigator
and who fully consent to participate.
For Parkinson Disease (PD):
- Patients followed for PD diagnosed according to international criteria for the
diagnosis of PD (MDS criteria),
- A MoCA score greater than 20/30
- No treatment with deep brain stimulation.
For REM Sleep Behavior Disorder (RBD):
- Diagnosis of RBD according to ICSD-3 criteria: presence on polysomnography of an
abnormal elevation of muscle tone during REM sleep (more than 18% of REM sleep
without chin atonia) and/or the presence of REM sleep behaviors on
video-polysomnography,
- Absence of progressive neurodegenerative pathology: absence of diagnostic criteria
for PD, multiple system atrophy, or Lewy body dementia.
For healthy controls:
- No neurological or psychiatric disease
Common to all groups:
- Age superior 18 years
- Patients who have received complete information about the study from an investigator
and who fully consent to participate.
For Parkinson Disease (PD):
- Patients followed for PD diagnosed according to international criteria for the
diagnosis of PD (MDS criteria),
- A MoCA score greater than 20/30
- No treatment with deep brain stimulation.
For REM Sleep Behavior Disorder (RBD):
- Diagnosis of RBD according to ICSD-3 criteria: presence on polysomnography of an
abnormal elevation of muscle tone during REM sleep (more than 18% of REM sleep
without chin atonia) and/or the presence of REM sleep behaviors on
video-polysomnography,
- Absence of progressive neurodegenerative pathology: absence of diagnostic criteria
for PD, multiple system atrophy, or Lewy body dementia.
For healthy controls:
- No neurological or psychiatric disease
Common to all groups:
- Pregnant or breastfeeding women
- Subjects under guardianship/conservatorship
- Persons deprived of liberty.